MedPath

Transpyloric Feeding for Prevention of Micro-aspiration

Active, not recruiting
Conditions
Microaspiration
Gastro Esophageal Reflux
Interventions
Other: Transpyloric feeding
Registration Number
NCT03646045
Lead Sponsor
Nemours Children's Clinic
Brief Summary

To determine the effect of transpyloric (TP) feeding on microaspiration and lung inflammation in ventilated preterm infants.

Detailed Description

Specific Aim 1): To determine the effect of TP feeding on microaspiration and lung inflammation. Hypothesis: TP feeding will reduce the microaspiration and pulmonary inflammation in ventilated preterm infants. Evaluate markers of microaspiration (pepsin A) and lung inflammation \[total cell counts, nuclear factor-kB (NF-kB) activation, tumor necrosis factor-α (TNF-α), IL-1β, IL-6, IL-8, angiopoietin 2 (Ang2), high-mobility group box-1 protein (HMGB1), macrophage migration inhibitory factor (MIF) and interferon-γ (IFN-γ)\] in TA samples obtained from preterm ventilated infants with and without TP feeding.

Specific Aim 2): To determine the effect of TP feeding on respiratory support. Hypothesis: TP feeding will decrease the respiratory severity score (RSS) \[Fraction of inspired oxygen (FiO2) X mean airway pressure (MAP)\] and number of infants requiring ventilator support. Evaluate respiratory support in preterm ventilated infants with and without TP feeding.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Preterm infants with birth weight <1500 grams
  • Requiring ventilatory support
Read More
Exclusion Criteria
  • Culture-proven sepsis
  • Ventilator associated pneumonia (VAP).
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Transpyloric feedTranspyloric feedingPreterm infant receiving transpyloric feeding.
Primary Outcome Measures
NameTimeMethod
Tracheal aspirate pepsin A levels in ventilated preterm infants receiving transpyloric feeding and gastric feeding.3-7 days

Difference in tracheal aspirate pepsin A levels in preterm ventilated infants receiving transpyloric feeding and gastric feeding.

Secondary Outcome Measures
NameTimeMethod
Respiratory support in ventilated preterm infants before and transpyloric feeding.7-14 days

Change in respiratory severity score (FiO2 X mean airway pressure) in preterm ventilated infants before and after transpyloric feeding.

Tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in ventilated preterm infants before and after transpyloric feeding.3-7 days

Change in tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in preterm ventilated infants before and after transpyloric feeding.

Tracheal aspirate pepsin A levels in ventilated preterm infants before and after transpyloric feeding.3-7 days

Change in tracheal aspirate pepsin A levels in preterm ventilated infants before and after transpyloric feeding.

Tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in ventilated preterm infants receiving transpyloric feeding and gastric feeding.3-7 days.

Difference in tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in preterm ventilated infants receiving transpyloric feeding and gastric feeding.

Respiratory support in ventilated preterm infants receiving transpyloric feeding and gastric feeding.7-14 days

Difference in respiratory severity score (FiO2 X mean airway pressure) in preterm ventilated infants receiving transpyloric feeding and gastric feeding.

Trial Locations

Locations (2)

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

AI duPont Hospital for Children

🇺🇸

Wilmington, Delaware, United States

© Copyright 2025. All Rights Reserved by MedPath